x

NEW UPDATE: Completed trials may now upload and register supplementary documents (e.g. null results reports, populated pre-analysis plans, or post-trial results reports) in the Post Trial section under Reports, Papers, & Other Materials.
An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties
Last registered on September 06, 2017

Pre-Trial

Trial Information
General Information
Title
An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties
RCT ID
AEARCTR-0002411
Initial registration date
September 01, 2017
Last updated
September 06, 2017 1:40 PM EDT
Location(s)
Primary Investigator
Affiliation
University of Michigan
Other Primary Investigator(s)
PI Affiliation
University of Michigan Center for Evaluating Health Reform
PI Affiliation
Center for Healthcare Research and Transformation
Additional Trial Information
Status
In development
Start date
2017-09-05
End date
2019-12-31
Secondary IDs
Abstract
This study will evaluate the effects of a program initiated through the Michigan Medicaid State Innovation Model in Washtenaw and Livingston counties.
External Link(s)
Registration Citation
Citation
Post, Brady, Andrew Ryan and Marianne Udow-Philips. 2017. "An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties." AEA RCT Registry. September 06. https://doi.org/10.1257/rct.2411-1.0.
Former Citation
Post, Brady et al. 2017. "An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties." AEA RCT Registry. September 06. http://www.socialscienceregistry.org/trials/2411/history/21214.
Experimental Details
Interventions
Intervention(s)
Patients randomized into the treatment group will receive care coordination services.
Intervention Start Date
2017-11-01
Intervention End Date
2018-12-31
Primary Outcomes
Primary Outcomes (end points)
Health care spending
Emergency department utilization
Secondary outcomes may include patient-reported outcomes of well-being, satisfaction with care, and others.
Primary Outcomes (explanation)
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
Eligible patients will be randomized into control or treatment groups. The treatment group will receive a care management intervention. Those in the treatment group will receive a needs assessment and assistance in navigating relevant health and community systems. Those assigned to the control group will transition to the treatment group six months after randomization.
Experimental Design Details
Randomization Method
Randomization done in office by a computer
Randomization Unit
Individual
Was the treatment clustered?
No
Experiment Characteristics
Sample size: planned number of clusters
0
Sample size: planned number of observations
We expect approximately 2,000 total individuals.
Sample size (or number of clusters) by treatment arms
We expect approximately 1,000 individuals per treatment arm.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
St. Joseph Mercy Ann Arbor Institutional Review Board
IRB Approval Date
2017-07-17
IRB Approval Number
IRB determined that the study should be classified with "Not Regulated" status.
Post-Trial
Post Trial Information
Study Withdrawal
Intervention
Is the intervention completed?
No
Is data collection complete?
Data Publication
Data Publication
Is public data available?
No
Program Files
Program Files
Reports, Papers & Other Materials
Relevant Paper(s)
REPORTS & OTHER MATERIALS